All sites C00-96,D32-33,D42-43,D45-47,D76 802 90.9 1.7 2.6 1.2 3.6
Mouth, pharynx C00-14 19 100.0 - - - -
  Lip C00 2 100.0 - - - -
  Tongue C02 5 100.0 - - - -
  Mouth, other C03-06 3 100.0 - - - -
  Salivary glands C07-08 1 100.0 - - - -
  Pharynx C01,C09-14 7 100.0 - - - -
Digestive organs C15-26 158 87.9 2.2 4.1 1.4 4.4
  Oesophagus C15 9 97.7 - - 2.3 -
  Stomach C16 19 92.5 1.1 2.2 - 4.3
  Small intestine C17 3 87.5 - - - 12.5
  Colon C18 43 96.7 - 0.9 0.5 1.9
  Rectum, rectosigmoid C19-20 32 95.7 - 1.2 0.6 2.5
  Anus C21 2 100.0 - - - -
  Liver C22 15 85.5 1.3 7.9 1.3 3.9
  Gallbladder, bile ducts C23-24 6 86.7 6.7 3.3 3.3 -
  Pancreas C25 23 64.7 8.6 15.5 3.4 7.8
  Other digestive organs C26 6 48.3 10.3 3.4 6.9 31.0
Respiratory organs C30-39 91 76.6 6.8 8.1 2.6 5.9
  Nose, sinuses C30-31 1 100.0 - - - -
  Larynx, epiglottis C32 5 100.0 - - - -
  Lung, trachea C33-34 85 75.0 7.3 8.7 2.8 6.1
  Mediastinum, pleura C38 0 100.0 - - - -
Bone C40-41 2 100.0 - - - -
Melanoma of the skin C43 27 100.0 - - - -
Skin, non-melanoma C44 37 98.9 - 1.1 - -
Mesothelioma C45 4 95.2 - - - 4.8
Autonomic nervous system C47 - - - - - -
Soft tissues C48-49 5 96.2 - - - 3.8
Breast C50 1 100.0 - - - -
Male genital organs C60-63 272 98.9 - 0.1 0.7 0.3
  Prostate C61 265 98.9 - 0.2 0.7 0.3
  Testis C62 5 100.0 - - - -
  Other male genital C60,C63 2 100.0 - - - -
Urinary organs C64-68 74 93.5 0.8 2.2 0.8 2.7
  Kidney C64 26 87.0 - 4.6 2.3 6.1
  Bladder and urinary tract2 C65-68 47 97.0 1.3 0.8 - 0.8
Eye C69 1 100.0 - - - -
Brain, central nervous system C70-72,D32-33,D42-43 19 85.4 - 9.4 2.1 3.1
Thyroid gland C73 5 100.0 - - - -
Other endocrine glands C74-75 1 100.0 - - - -
Illdefined or unknown C76,C80 16 65.0 6.3 10.0 3.8 15.0
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 70 77.7 4.0 1.7 2.3 14.3
  Hodgkin lymphoma C81 3 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 33 98.8 - - - 1.2
  Malignant immunoproliferative diseases C88 1 100.0 - - - -
  Myeloma and other plasma cell tumors C90 10 60.8 5.9 9.8 7.8 15.7
  Leukaemia C91-95 16 71.8 7.7 1.3 2.6 16.7
  Myelodysplastic syndromes D46 6 3.6 17.9 - 7.1 71.4
  Myeloproliferaitive neoplasms D45,D47 2 36.4 - - - 63.6
Not included above
  Basal cell carcinoma of the skin 105 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.